Affini-T Therapeutics is based in Boston, Massachusetts. It has raised $175M in total funding. Latest round: Seed.
Affini-T Therapeutics funding overview
Affini-T Therapeutics is based in Boston, Massachusetts. Affini-T Therapeutics has raised $175M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed announced in March 2022. The round record for Affini-T Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Vida Ventures, Leaps by Bayer, Humboldt Fund, The Parker Institute for Cancer Immunotherapy, Catalio Capital Management, Agent Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
Affini-T Therapeutics at a glance
Total raised
$175M
Latest round
Seed
Latest round date
March 2022
Headquarters
Boston, Massachusetts
Notable investors
Vida Ventures, Leaps by Bayer, Humboldt Fund, The Parker Institute for Cancer Immunotherapy, Catalio Capital Management, Agent Capital, Alexandria Venture Investments, Erasca Ventures
Frequently asked about Affini-T Therapeutics funding
How much has Affini-T Therapeutics raised?
Affini-T Therapeutics has raised $175M in total disclosed funding across the rounds on record.
Who has invested in Affini-T Therapeutics?
Vida Ventures, Leaps by Bayer, Humboldt Fund, The Parker Institute for Cancer Immunotherapy, Catalio Capital Management, Agent Capital are named among the investors backing Affini-T Therapeutics.
What was the latest Affini-T Therapeutics funding round?
The most recent disclosed round is a Seed, announced in March 2022.
Where is Affini-T Therapeutics based?
Affini-T Therapeutics is based in Boston, Massachusetts.
When did Affini-T Therapeutics last raise?
The last disclosed Affini-T Therapeutics round closed in March 2022 at Seed.
Affini-T Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
